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Summary 
Thymocytes must bind major histocompatibility complex (MHC) proteins on thymic epithelial 
cells in order to mature into either CD8 + cytotoxic T  cells or CD4 + helper T  cells.  Thymic 
precursors express both CD8 and CD4, and it has been suggested that the intracellular signals 
generated by CD8 or CD4 binding to class I or II MHC, respectively, might influence the fate 
of uncommitted  cells.  Here we test the notion that intracellular signaling by CD4 directs the 
development of thymocytes to a CD4 lineage. A  hybrid protein consisting of the CD8 extra- 
cellular  and  transmembrane  domains  and  the  cytoplasmic  domain  of CD4  (CD884)  should 
bind class  I MHC  but deliver a  CD4 intracellular signal. We find that expression of a hybrid 
CD884 protein in thymocytes oftransgenic mice leads to the development of large numbers of 
class I MHC-specific, CD4 lineage T  cells.  We discuss these results in terms of current models 
for CD4 and CD8 lineage commitment. 
T 
he differentiation of immature thymocytes into either 
CD4 §  or CD8 + mature T  cells is linked to the speci- 
ficity of the  TCRs  expressed  on  developing  thymocytes. 
Recognition of class I MHC by developing thymocytes re- 
quires  the  coordinate  binding  of both  a  class  I-specific 
TCR  and a  CD8  coreceptor,  and can give rise  to mature 
CD8 + T  cells.  In contrast, recognition of class II MHC  re- 
quires corecognition by a class II-specific TCR and the CD4 
coreceptor and can give rise to mature  CD4 + T  cells.  Al- 
though immature thymocytes express both CD4 and CD8, 
as thymocytes mature, they downregulate expression of one 
of the  coreceptors,  giving rise  to  mature  CD4+CD8 -  or 
CD4-CD8 § T  cells.  Thus lineage commitment in the thy- 
mus is linked  to both  the  specificity of the  TCR  and the 
expression of the CD4 and CD8 coreceptors. 
The observation that the specificity of TCR  for class I or 
II MHC influences the choice between CD4 and CD8 lin- 
eages is consistent with a model in which binding of class I 
MHC by a CD4+CD8 + thymocyte leads to the downregu- 
lation  of CD4  expression  and commitment to a CD8 fin- 
eage.  Likewise,  binding of class  II MHC  may lead  to the 
downregulation  of CD8  expression  and  commitment to a 
CD4  lineage  (1).  This  model  fits  well  with  observations 
from TCR  transgenic mice,  in which expression of a class 
I-specific TCR  generally leads  to  an increase  in the  pro- 
duction of mature CD8  cells,  and expression  of a class  II- 
specific TCR  generally leads to an increase in the produc- 
tion of mature CD4 cells  (2-5). 
The analysis of  putative transitional intermediates in MHC- 
deficient mice has been interpreted as evidence against an in- 
structive model. For example, a population of CD4+CD8  l~ 
thymocytes is observed in mice mutant for class  II MHC, 
but is missing in mice mutant for both class I and II MHC 
(6,  7).  It has been proposed (7)  that this population repre- 
sents class I-selected transitional cells that are committed to 
a CD4 lineage, a population that would not be predicted by 
an instructive model. There is, however, no direct evidence 
that the CD4+CD8  l~  cells are the precursors of CD4 lineage 
cells.  Indeed, recent experiments indicate that at least some 
CD4+CD8  ]~  thymocytes  give  rise  to  CD8  lineage  cells 
(8), raising questions about the implications of this population 
for the mechanism of CD4/CD8 lineage commitment. 
Another line of evidence that lineage commitment need 
not correlate with MHC  specificity comes from mice ex- 
pressing  constitutive  CD8  or CD4  transgenes  (9-15).  Al- 
though these experiments provide evidence for a stochastic 
component to lineage  commitment,  it  is  striking  that  the 
generation  of T  cells  of the  "wrong"  lineage  (i.e.,  CD4 § 
with class  I-specific TCRs or CD8 + with class  II-specific 
TCRs) is invariably inefficient.  For example, class II MHC 
mutant,  CD8  transgenic  mice have only ~3%  of the  ma- 
ture CD4 § thymocytes that are found in mice that are wild 
type for class II MHC  (10). Moreover, another class I-spe- 
cific  TCR,  anti-HY,  failed  to  give  rise  to  any  detectable 
CD4 lineage cells when coexpressed with a CD8 transgene 
(16-18),  implying  that  not  all  class  I-specific  TCRs  can 
permit the development of CD4 lineage cells. 
In light of these considerations,  we decided to examine 
more directly the  question  of whether intracellular  signals 
generated upon MHC recognition might influence the fate 
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pothesis that CD4  intracellular signals promote the devel- 
opment of CD4 lineage T  cells. A  hybrid molecule consist- 
ing of the extracellular domain of CD8 and the cytoplasmic 
domain of CD4  would be expected to bind class I  MHC, 
yet deliver a CD4 intracellular signal. If CD4 signals direct 
thymic precursors to choose~the CD4 lineage, then the rec- 
ognition of class II MHC  by thymocytes expressing such a 
hybrid molecule would direct development to  a  CD4  in- 
stead of a  CD8  lineage. Indeed, we find that coexpression 
of a hybrid CD8/4  molecule with the F5 TCR  leads to a 
dramatic increase in  mature  CD4  cells, and  a  decrease in 
mature CD8  cells. These results indicate that the cytoplas- 
mic domain of CD4 delivers a signal that favors the devel- 
opment of CD4 lineage cells. 
Materials and Methods 
Generation of Transgenic Mice Expressing  CD884  Hybrid  Moleo 
cules.  A Nael site was introduced into the CD8.1 cDNA (16) at 
amino acid 196 by site-directed mutagenesis. The sequence of the 
mutagenic oligonucleotide was 5'-aac acg ctg ccg gct cct gtg-3'. 
This Nael site was ligated to the existing Nael site at amino acid 
400  of the murine CD4 gene. The resulting hybrid cDNA en- 
codes  a  fusion protein whose  extracellular and  transmembrane 
domains derive from the CD8 gene (through amino acid Ser 195 
[19]),  and whose cytoplasmic domain derives from CD4  (from 
amino acid Arg 400  [20]).  The hybrid cDNA was inserted into 
the EcoR.I site of the human CD2 expression cassette, to produce 
a transgenic construct that is analogous to the "Tll-8" construct 
that was used to generate CD8.1  transgenic mice (16). This con- 
struct was coinjected along with a CD813.1 genomic clone (21) into 
C57B1/10  embryos.  One  founder  which  expresses  transgenic 
CD8.~xl  and  CD813.1 at levels comparable to  the  endogenous 
CD8 genes was chosen for further analysis. Hematopoietic stem cell 
chimeras were generated by injecting mixtures ofT cell-depleted 
bone marrow cells from F5 TCR  and F5 TCR/CD884  trans- 
genic mice (2  ￿  107 cell/recipient) into unirradiated P,.agl  mu- 
tant mice (22). 
Analysis of Lck Association.  Thymocytes (107 cells/sample) were 
lysed in 1 ml oflysis buffer (50 mM Tris, pH 7.5, 0.1% NP-40, 
1 mM Na3VO4,  10 mM NaF, 10 mM Na4P207,  1 mM PMSF, 
10 l~g/ml aprotinin, and 10 p~g/ml leupeptin). Lysates were cen- 
trifuged for 1 min at 14,000  rpm and the supematants were incu- 
bated with  25  Ixl protein G  beads  (GammaBind G  Sepharose; 
Pharmacia, Piscataway, NJ)  that had been precoated with either 
anti-CD4 (GK1.5) or anti-CD8 (53-6.72). After 3 h at 4~  beads 
were washed twice with lysis buffer without detergent. Nonreduc- 
ing SDS loading buffer was added to the  samples,  which were 
heated for 5 min at 95~  Samples were run on an SDS polyacryl- 
amide gel and transferred to nitrocellulose (Hybond-ECL; Amer- 
sham  Corp., Arlington Heights,  IL).  Irnmunoblotting was per- 
formed  using  the  enhanced  chemiluminescence  system  (ECL; 
Amersham Corp.) according to  the manufacturer's instructions. 
Anti-Lck antibody was kindly provided by Dr. Joe Bolen (Bris- 
tol-Myers Squibb, Princeton, NJ) and was visualized using horse- 
radish peroxidase goat anti-mouse Ig (Southern  Biotechnology 
Associates, Birmingham, AL). 
Analysis of Lck Activation.  CD8  and  CD884  constructs were 
cloned into a  SV40  expression cassette  (23)  and introduced by 
electroporation into Jurkat cells along with a selectable plasmid. 
Individual hygromycin B  resistant clones expressing comparable 
cell surface levels of CD8 were selected for cross-linking experi- 
ments. Cross-linking was performed as follows. 107 cells were in- 
cubated with 20 Ixg rat anti-murine CD8 IgG (clone 53-6.72) for 
15 min on ice, then with 60 Ixg goat anti-rat IgG (Cappel Labo- 
ratories, Durham, NC) for 15 rain on ice. Cells were then incu- 
bated for 10 min at 37~  rinsed with cold PBS containing 1 mM 
Na3VO  4 and 10 mM NaF, and lysed for 20 min in lysis buffer on 
ice. Lysates were cleared by centrifugation for 10 min at 10,000 g 
and incubated with 25  Ixl protein G beads for 6 h at 4~  Beads 
were then washed four times with lysis buffer (without Na4P207 
and PMSF), once with kinase buffer (50 mM Hepes, pH 7.5, 100 
mM NaC1, 5 mM MgC12, and 5 mM MnC12) , and resuspended in 
30  Ixl kinase buffer containing 10  I~Ci ~/-[32p]ATP  and  10  Ixg 
acid-denatured enolase  (Sigma Chemical Co.,  St.  Louis,  MO). 
Reactions were run for 10 min at 30~  quenched with 15 I~1 3￿ 
sample buffer (150 mM Tris, pH 6.8, 30% glycerol, 6% SDS, 3% 
2-ME and 0.05% bromophenol blue), and reaction products were 
analyzed by SDS-PAGE. The gel was then fixed and dried for au- 
toradiography. Quantification of radioactive bands was performed 
using the Phosphorlmager/ImageQuant system (Molecular Dy- 
namics,  Sunnyvale,  CA).  For the in vitro kinase assay on  thy- 
mocytes, immunoprecipitations were performed as described above 
for the Western blot.  Immunoprecipitates were resuspended in 
kinase buffer and assays were performed as described above. 
Analysis of T Cell Populations.  Class II MHC mutant, anti-HY 
and F5 TCR transgenic mice have been previously described (3, 
24, 25). All mice were homozygous for H-2  b. Cell suspensions of 
thymocytes and lymph node T  cells were prepared and labeled 
with fluorescent antibodies as previously described (11). For anal- 
ysis of mature thymocytes, thymocytes were  treated with anti- 
heat  stable antigen  (HSA)  1 and  complement as  previously de- 
scribed (10).  Antibodies used were T3.70  (culture supematant), 
PE-labeled goat  anti-mouse  IgG1  (Caltag  Laboratories,  South 
San Francisco, CA), PE-labeled CD4 (Beckton Dickinson & Co., 
Mountain  View,  CA),  anti-CD8.2~  FITC  (2.43),  Tricolor  xM- 
labeled streptavidin (Caltag), and rat gamma globulin (Calbiochem- 
Novabiochem  Corp.,  San  Diego,  CA),  anti-CD8.1  (49-31.1; 
Cedarlane Laboratories, Westbury, NY), FITC-labeled goat anti- 
mouse  IgG3  (Caltag), biotinylated anti-CD4  (YTS  191.1;  Cal- 
tag), biotinylated anti-Vet2  (PharMingen,  San Diego,  CA), and 
biotinylated anti-VI311  (KT11).  Data  (50,000  events) were col- 
lected and analyzed using a FACScan  |  flow cytometer (Becton 
Dickinson & Co.) or X-cell flow cytometer (Coulter Corp., Hi- 
aleah, FL). Dead cells were excluded on the basis of forward and 
side scatter. 
Results 
Transgenic Mice Expressing  a  Hybrid  CD8/CD4  Transgene. 
To redirect a CD4 intracellular signal, we constructed a hy- 
brid cDNA  consisting of the  extracellular and  transmem- 
brane domains of CD8a and the cytoplasmic domain of CD4 
(CD884).  The CD8o~ cDNA used encodes the CD8.1  al- 
lele, which can be distinguished from the endogenous CD8 
allele  (CD8.2)  using  monoclonal  antibodies.  The  hybrid 
cDNA  (Fig.  1  a)  was  inserted into  an  expression cassette 
containing  the  human  CD2  promoter,  minigene,  and  3' 
locus controlling region, to generate a  construct analogous 
1Abbreviations used in this paper: HSA, heat stable antigen; NP, nucleopro- 
tein. 
732  Development of CD4 Lineage T Cells Figure 1.  Redirecting a CD4 intraceUular signal with a hybrid CD8/CD4 coreceptor. (a) Construct used in the generation of  CD884 transgenic mice. 
(White) Transmembrane domain. (Arrow) Direction of transcription; the sequence surrounding the fusion is depicted below. (Underlined) Nael  site. The 
map is not drawn to scale.  Restriction endonuclease sites:  Sall  (S), BamH1  (/3), and Xbal  (X).  The CD884  transgene was coinjected with a  15-kb 
BamH1  genonfic fragment encoding CD813.1 (21)  into  C57B1/10  embryos.  (b)  CD884  protein is more effective than CD8 in activating Lck.  The 
CD884 and CD8 cDNAs were cloned into a SV40 expression vector and used to transfect the human T  cell line Jurkat. Anti-CD8 immunoprecipitates 
from stable transfectants  expressing comparable levels ofmurine CD8 cell were analyzed using an in vitro kinase assay as described in Materials  and Methods. 
Lck activity was quantitated by integrating signals of enolase bands. (Arrows) Migration positions of  Lck and enolase. (Le~) Migration positions of molecular 
weight (kDa)  standards. (c) CD8a expression on CD884 and CD8.1  transgenic (tg) mice. Thymocytes were stained with anti-CD8~t, which recognized 
both endogenous and transgenic CD8.  (d) CD813.1  expression on CD884  and CD8.1  transgenic mice. Thymocytes were stained with anti-CD8[3.1, 
which recognizes transgenic, but not endogenous CD813.  (e) Lck associated with CD4 and CD8 in thyrnocytes of CD884 and CD8.1  transgenic mice. 
Thymocytes from the indicated mice were subjected to immunoprecipitation with the indicated antibodies. Immunoprecipitates were resolved by PAGE 
and analyzed by Western blot analysis using anti-Lck antibodies. The experiment was performed twice with equivalent results.  (jr) Active Lck associated 
with CD4 and CD8 in thymocytes of CD884 and CD8.1 transgenic mice. Thymocytes from the indicated mice were subjected to immunoprecipitation 
with the indicated antibodies, lmmunoprecipitates were then subjected to in vitro kinase assays as described in Materials and Methods. The experiment 
was performed twice with equivalent results. 
733  Itano et al. Table 1.  Thymocytes  and Lymph Node T Cells  fiom CD884 Transgenic Mice 
Percent total thymocytes  Percent HSA-Thymocytes 
No. of cells/thymus  TCR.  +  TCR  + 
Genotype  X  10  6  CD4  + 8.2-  CD4- 8.2 +  CD4 + 8.2-  CD4- 8.2 + 
%  % 
Nontransgenic  225 (126)  7.1 (1.7)  2.4 (0.9)  -  -  5 
CD884 transgenic  171  (66)  10  (2.6)  2.3 (0.6)  -  -  8 
Class II-  230  (33)  1.3 (0.3)  2,9 (0.4)  2.4 (0.6)  68 (5.6)  3 
Class II-/CD884 transgenic  193  (61)  5.1 (0.6)  2,2 (0.2)  26 (7.5)  49 (3.3)  3 
Percent lymph node T cells 
CD4  + 8.2-  CD4- 8.2 +  4:8 ratio  n 
% 
Nontransgenic  56  (3,4)  38 (3.2)  1,5  9 
CD884 transgenic  63  (5.2)  24 (2.5)  2.6  8 
Class II-  3.4 (0.2)  88 (4.2)  0.04  3 
Class II-/CD884 transgenic  33  (2.2)  58 (1,6)  0.6  3 
Total thymocytes, mature thymocytes (HSA depleted), or lymph node T cells (B cell depleted) were stained with antibodies against TCR, CD4, and 
CD8.2 (endogenous CD8), as described in Materials and Methods. CD884 transgenic mice were either heterozygous or homozygous for the CD884 
transgene. Average values are given with standard deviations in parentheses, and n is the number of mice analyzed of each genotype. 
to one previously used to direct constitutive expression of a 
wild-type CD8 cDNA (16, 26). 
To  test whether  the  CD4  cytoplasmic domain  is func- 
tional in the context of the CD884 protein,  we examined 
the ability of the CD884 molecule to activate the tyrosine 
kinase  p56  lck  (Lck).  Although the  cytoplasmic domains  of 
both CD4 and CD8 interact with Lck, cross-linking of CD4 
activates Lck more strongly than does cross-linking of CD8 
(27-29).  We  introduced  both  the  CD884  and  the  wild 
type-CD8 constructs into the human T  cell line Jurkat, and 
isolated  stable  transfectants  expressing  comparable  surface 
levels of either CD884 or wild-type CD8. Transfectants were 
then subjected to cross-linking using antimurine CD8 anti- 
bodies,  and in vitro kinase  assays were performed on anti- 
CD8  immunoprecipitates.  We  find  that  cross-linking  of 
CD884  molecules leads to approximately  eightfold higher 
activation of Lck than does cross-linking of wild-type CD8 
(Fig.  1  b).  This  indicates  that  the  cytoplasmic  domain  of 
CD4,  when  fused to the  extracellular  and transmembrane 
domain of CD8, activates Lck more strongly than does the 
cytoplasmic domain of CD8. 
Although CD8ct can be expressed as a homodimer,  it is 
generally found as a heterodimer paired with a [~ chain, and 
recent evidence indicates that the [~ chain of CD8 plays an 
important role in thymic development (30-32).  To ensure 
that CD8[3 is not limiting,  and to mimic more closely the 
original  CD8  transgenic  mice,  we  coinjected  a  genomic 
clone  encoding CD813  (21)  along with  the  CD884  trans- 
genic construct. A line that expresses CD884 and CDSJ3 on 
virtually all thymic and peripheral T  cells at levels compara- 
ble to endogenous CD8 was chosen for further analysis.  The 
cell surface expression of CD8~x on thymocytes of CD884 
transgenic mice is comparable to endogenous CD8 expres- 
sion and is very similar to the levels on previously described 
CD8.1  transgenic mice (Fig.  1 c). Both CD884 and CD8.1 
transgenic  mice  also  express  comparable  surface  levels  of 
CD813.1  (Fig.  1 d). 
Because the cytoplasmic domain of CD4 associates strongly 
with Lck, we suspected that thymocytes from CD884 trans- 
genic mice would have more CD8-associated Lck than thy- 
mocytes from nontransgenic or CD8.1 transgenic mice. To 
investigate  this  question,  we prepared  anti-CD8  and anti- 
CD4 immunoprecipitates from thymocytes ofnontransgenic, 
CD884  transgenic,  and  CD8.1  transgenic  mice,  and  per- 
formed both in vitro  kinase  assays  and  anti-Lck.  Western 
blot analysis (Fig.  1, e and f). As expected, we found an in- 
crease in both Lck immunoreactivity  (Fig.  1 e) and kinase 
activity  (Fig.  1 f)  in  anti-CD8  immunoprecipitates  from 
CD884  transgenic  mice relative  to nontransgenic  or CD8 
transgenic mice. It is also interesting to note that anti-CD8 
immunoprecipitates from thymocytes ofCD8 transgenic mice 
have an increased association with Lck relative to nontrans- 
genic mice. This may reflect the fact that the level of CD8 
expression in thymocytes of CD8 transgenic mice is slightly 
elevated relative to nontransgenic,  and/or the fact that the 
CD8  transgene  does  not  encode  CD8od,  an  alternative 
splice version of CD8 that cannot associate with Lck (33). 
Class 1-specific, CD4  Lineage T  Cells Develop in  CD884 
Transgenic Mice.  In our initial analysis  ofCD884 transgenic 
mice, we examined thymocytes and lymph node T  cells for 
734  Development of CD4 Lineage T Cells Total Thymus 
F5 TCR tg  F5 TCR/ 
CD8.1 tg 
8 
12.3_~ r  '~t4! 
Z 
CD8.2 
F5 TCR 
F5 TCR/ 
CD884 tg 
CD8.1 
Figure 2.  Thymic subsets in mice coexpressing the F5 TCR and the 
CD884  transgenes. Expression of CD4  and CD8.2  (endogenous CD8) 
(a-c), V1311 (d-f), or CD8.1 (transgenic CDS) (g--t)  in thymocytes from 
F5 TCR (a, d, andg), F5 TCIq./CD8.1  (b, e, and h) or F5 TCR/CD884 
(c, f, and t) transgenic mice. Thymocytes were analyzed with fluorescent 
antibodies as described in Materials and Methods. The numbers inside the 
quadrants represent the percentage of cells in each population. 
expression of TCR.,  CD4,  and endogenous  CD8  (CD8.2) 
by flow cytometry (Table  1).  It is interesting to note that 
we observed a slight increase in the ratio of mature CD4 to 
CD8  T  cells in  the  lymph  node  and  thymus  of CD884 
transgenic mice. This increase in the ratio of CD4 to CD8 
cells is consistent with the possibility that both class I- and 
II-specific T  cells are present in the mature  CD4  popula- 
tion in CD884 transgenic mice. 
If mature  CD4 +  T  cells in  CD884  transgenic mice  are 
selected on class I MHC,  they should not be dependent on 
class  II  MHC  for  their  development.  To  examine  this 
question,  we  backcrossed  the  CD884  transgene  to  mice 
that  are  deficient for class II MHC  because  of a  targeted 
disruption of the I-A 13 gene  (24). Whereas class II MHC 
mutant mice have very few peripheral CD4  cells (24,  34), 
the ratio of peripheral CD4  to CD8  cells in CD884  trans- 
genic, class II mutant mice is 0.6, compared to 1.5 in mice 
that are wild type for class II MHC  (Table 1). 
There  is  also  a  substantial population  of mature  CD4 
cells (TCRhig~CD4+CD8.2 -) in the thymus ofCD884 trans- 
genic, class II mutant mice  (Table  1).  To more accurately 
determine  the  ratio  of mature  CD4  to  CD8  thymocytes, 
we depleted thymocytes of immature cells by treating them 
with anti-HSA and complement. The resulting mature thy- 
mic population was then analyzed for expression of TCR., 
CD4,  and  CD8.2.  When  analyzed in  this  manner,  non- 
transgenic mice have a ratio of mature CD4 to CD8 cells of 
approximately 2, whereas class II-deficient mice show a ra- 
tio  of <0.05  [10].  In  contrast,  expression  of the  CD884 
transgene in a  class II mutant background results in a  thy- 
mic  CD4  to  CD8  ratio  of 0.5.  As previously shown,  ex- 
pression  of a  wild-type CD8  transgene  in  class  II  MHC 
mutant mice also restores the development of some mature 
CD4  thymocytes, however the CD4  to CD8  ratio is only 
0.08 in CD8 transgenic, class II mutant mice (10). This is in 
spite of the fact that the surface expression of the wild-type 
CD8 transgene is slightly higher than the CD884  transgene 
(Fig. 1 c and Fig. 2, h and i). Thus the CD884  molecule is 
much more efficient than wild-type CD8 at permitting the 
development of class I-selected CD4 lineage T  cells. 
The Effect of the  CD884  Transgene on Selection of the F5 
TCR.  We also examined the effect of the CD884  trans- 
gene expression on the selection of two individual class 1-spe- 
cific TCRs,  F5  and  anti-HY.  The  F5  TCR  recognizes a 
nucleoprotein peptide bound to the class I  MHC  protein, 
H-2D  b,  and  mice  expressing an  F5  TCR  transgene  have 
greatly increased numbers of mature CD8 thymocytes and 
very few mature CD4  thymocytes (25; Table 2  and Fig. 2 
a). It is striking that in mice expressing both the F5 TCR 
Table 2.  Thymocytes  and Lymph Node T Cells  fiom Mice Coexpressing the F5 TCR and CD884 Transgenes 
Percent total thymocytes 
No. of ceUs/thymus 
Genotype  ￿  106  CD4 + 8.2-  CD4- 8.2 +  4:8 ratio  n 
F5 TCR transgenic  198  (97)  2.4 (0.9)  15  (4.6)  0.2  6 
F5 TCR/cd884 transgenic  114 (20)  50  (8.9)  7.4 (1.6)  6.8  6 
Percent lymph node T cells 
CD4 + 8.2-  CD4- 8.2 +  4:8 ratio  n 
F5 TCR transgenic 
F5 TCR/CD884 transgenic 
7.6 (1.2)  87 (1.7)  0.1  6 
56  (15)  32 (11)  1.8  8 
Thymocytes or lymph node T cells (B cell-depleted  lymph node cells) were stained with antibodies against CD4 and CD8.2 (endogenous CDS) as 
described in Materials and Methods. Representative  data are shown in Figs. 2 and 3. Average values are given with standard deviations in parenthe- 
ses, and n is number of mice of each genotype analyzed. 
735  Itano et al. and the CD884 transgenes,  this pattern is reversed (Fig. 2 c 
and Table 2). In the thymus ofF5 TCR/CD884  transgenic 
mice,  the  mature  CD4  subset  represents  "~50%  of thy- 
mocytes and  the  mature  CD8  subset  is  reduced  approxi- 
mately twofold compared to F5 TCR  transgenic mice. Ex- 
pression  of a  wild-type  CD8  transgene  also  leads  to  an 
increased number of mature CD4 cells  (11,  and Fig. 2  b); 
however,  this  effect  is  much  less  dramatic  than  that  ob- 
served  with  the  CD884  transgene,  in spite  of the  higher 
level  of expression  of the  CD8  transgene  (Fig.  1,  c and  d 
and Fig. 2, h and 0- Moreover, in F5 TCR/CD884  trans- 
genic mice, the increase in the CD4 subset is accompanied 
by a decrease in the mature CD8 subset. 
A  similar  trend  is  observed  in  the  lymph  node  of F5 
TCR/CD884  transgenic  mice  (Fig.  3  and  Table  2).  The 
average ratio of  CD4 to CD8 cells is 1.8 in F5 TCR/CD884 
transgenic mice, compared to 0.1 in F5 TCR and 0.3 in F5 
TCR/CD8.1  transgenic  mice  (11).  The  majority  of the 
CD4  cells  in  the  lymph node  of F5  TCR/CD884  trans- 
genic mice also express V~I 1 (Fig. 3f), consistent with the 
notion that they express the F5 TCR. Because some rear- 
rangements  of the  endogenous  TCR  genes  can  occur in 
TCR  transgenic mice, however, it is important to confirm 
that the CD4 + T  cells express the F5 TCR  rather than en- 
dogenous TCRs. Because there is no anticlonotypic antibody 
F5 TCR/  F5TCR/ 
F5TCRtg  CD8.1tg  CD884tg 
7.'5~  70 
CD8.2 
~d I ~68  I~ el 116 __[r  f] 
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Figure 3.  Lymph node T cells in mice coexpressing the F5 TCR and 
the CD884 transgenes. Expression of CD4, CD8.2 (endogenous CD8), 
V[B11 (transgenic TCR[3), and Vct2 (endogenous V~x) in lymph node T 
cells from F5 TCR (a, d,g, and/), F5 TCR/CD8.1 (b, e, h, and k), or F5/ 
CD884 (c, f, i, and/) transgenic mice. The numbers inside the quadrants 
represent the percentage of cells in each population. Numbers in paren- 
theses represent the frequency ofV~x2  + cells as a percentage of CD8.2  + T 
cells (g-i) or as a percentage of CD4 + T cells (/-q). T cells (B-depleted 
lymph node cells) were analyzed  with fluorescent antibodies as described 
in Materials and Methods. 
8 
r~ 
Spleen 
F5 TCR tg  FS TCR/ 
CD4-CD8.2+ 
Thymus 
F5 TCR tg  F5 TCR/ 
CD884 tg 
CD4-CD8.2+  CD4-CD8.2+ 
CD884 tg 
CD4-CD8.2+ 
CD4+CD8.2-  CD4+CD8.2-  CD4+CD8.2-  CD4+CD8.2- 
Anti-IL-2 receptor 
Figure  4.  Expression of [L-2 receptor after in vitro stimulation with 
NP peptide. Splenocytes (a-d) or thymocytes (e-h) from F5 TCR or F5 
TCR/CD884 transgenic mice were incubated with NP peptide and H-2  b 
splenocytes for 48 h and analyzed for expression of CD4, endogenous 
CD8 (CD8.2), and IL-2 receptor as described in Materials and Methods. 
IL-2 receptor levels on gated CD4+CD8.2  - and CD4-CD8.2 + popula- 
tions are shown. 
available  to  the  F5  TCR,  we  took  two  alternative  ap- 
proaches  to address  this  question.  First,  we  examined  ex- 
pression of an endogenous Vow, Vet2 (Fig. 3, g-/). Whereas 
V0~2 is normally expressed on 8-15% of  mature T  cells from 
normal mice (35, and data not shown), <0.5% of the CD8 + 
T  cells  from  F5  TCR,  F5  TCR/CD8.1,  or  F5  TCR/ 
CD884 transgenic mice express Vet2  (11,  and Fig. 3, g-0, 
consistent with the notion that the F5 TCR ci and [3 chains 
are expressed on these cells.  In contrast,  13% of the CD4 + 
T  cells from F5 TCR  transgenic mice express VoL2 (Fig. 3 
j),  consistent with the notion that these cells were selected 
using endogenous TCRs.  It is striking that only 2% of the 
CD4 + T  cells  in F5 TCR/CD884  transgenic mice express 
Va2  (Fig.  3  I), implying they, like the  CD8 + T  cells,  ex- 
press the F5 TCR. 
As an additional  confirmation that  CD4 +  T  cells  in  F5 
TCR/CD884  transgenic  mice  express  the  F5  TCR,  we 
also examined the response ofT cells from mice to nucleo- 
protein  (NP) peptide as measured by IL-2 receptor induc- 
tion. Although >90% ofCD8 + T  cells from both F5 TCR 
and F5 TCR/CD884  transgenic  mice expression  IL-2 re- 
ceptor  upon  stimulation  with  NP  peptide  (Fig.  4,  a-f), 
only '~10% ofCD4 + T  cells from F5 TCR are IL-2 recep- 
tor  positive  after  stimulation  (11,  and  Fig.  4,  c and g).  In 
contrast,  >90%  of CD4 §  T  cells  from  F5  TCR/CD884 
transgenic  mice  express  IL-2 receptor  in  response  to  NP 
peptide  (Fig.  4,  d and h),  confirming that they express the 
F5 TCR. 
Competition for Limiting  "Niches" Does Not Account  for the 
Reduction in CD8 Lineage Cells in F5 TCR Transgenic Mice. 
The decrease in the mature CD8 thymocytes in F5 TCR/ 
CD884 transgenic mice (Table 2) is consistent with the no- 
tion  that  the  CD884  transgene  is  causing  uncommitted 
thymocytes to switch fates and choose the CD4 instead of 
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tion for the  decrease  in the  mature  CD8 population;  that 
the  large  number  of mature  CD4  cell  thymocytes in  F5 
TCR/CD884  transgenic mice are preventing CD8 lineage 
cells from being selected because  of competition between 
CD4 and CD8 lineage cells for limiting niches in the thy- 
mus  (36).  If cellular competition for limiting niches is the 
explanation for the  reduction  in the  CD8  population,  we 
could  expect  the  proportion  of CD8  lineage  cells  within 
the F5 TCR/CD884  transgenic cells to increase as the pro- 
portion  of F5  TCR+CD884 +  thymocytes  decreases.  On 
the  other  hand,  if the  CD884  transgene  is  diverting  thy- 
mocytes from the  CD8  into  the  CD4 lineage,  we would 
expect the ratio of mature CD4 to CD8 lineage cells to re- 
main constant as the proportion ofF5 TCR/CD884  trans- 
genic thymocytes decreases. To investigate this question, we 
constructed mixed hematopoietic  stem cell chimeras from 
bone marrow of F5 TCR  and F5 TCR/CD884  transgenic 
mice.  3  wk  after  reconstitution,  we  analyzed thymocytes 
for  expression  of CD4,  endogenous  CD8  (CD8.2),  and 
transgenic CD8 (CD8.1). As shown in Table 3, there is no 
correlation between the proportion of thymocytes that are 
derived  from  F5  TCR/CD884  transgenic  bone  marrow 
and the relative proportion of mature  CD4  and CD8 lin- 
eage  cells within  this population.  These  data indicate  that 
cellular  competition  for limiting  niches  does  not  account 
Table 3.  Ratio of Mature CD4 to CD8 Lineage Thymocytes in 
Mixed Hematopoetic Stem Cell Chimeras  fiom F5 TCR/CD884 
Transgenic and F5 TCR Transgenic Mice 
Percent thymocytes derived 
from F5 TCR/CD884 
transgenic  donor (CD8.1 +) 
Ratio of 
CD4  +CD8.2-/CD4-CD8.2 + 
thymocytes within the 
F5 TCR/CD884- 
derived subset (CD8.1+ 
3.4  3.6 
20  2.8 
20  12 
23  3.8 
32  6.3 
54  4.2 
81  3.7 
87  4.8 
89  3.6 
Mixed hematopoetic stem cell chimeras were generated by reconstitut- 
ing the immune systems of Rag1 mutant mice with mixtures of bone 
marrow from F5 TCR/CD884 and F5 TCR transgenic mice. After 
3-4 wk to allow reconstitution, thymocytes were analyzed by flow cy- 
tometry for expression of CD8.1  (as a marker for F5 TCR/CD884 
transgene-derived cells), CD4, and endogenous CD8 (CD8.2). Thy- 
mocytes that  were  CD4-  and CD8.2-  (double negative) were  ex- 
cluded from the analysis because their genotype could not be assessed. 
The percentage of remaining thymocytes that expressed the  CD884 
transgene (CD8.1 +) is indicated. Each line represents the data from an 
individual chimera. 
for  the  reduction  in  the  mature  CD8  population  in  F5 
TCR/CD884  transgenic mice. 
The Effect of the CD884 Transgene on Selection of the anti-HY- 
TCR.  We also examined the effect of the CD884 transgene 
on selection of the anti-HY TCR. This TCR  recognizes a 
male  antigen  bound  to  the  class  I  molecule,  H-2D  b.  In 
the thymus of female anti-HY TCR transgenic mice, there 
is a substantial population of CD4-CD8 + cells that express 
high levels  of the  anti-HY  TCR,  but  very few  anti-HY 
TCR+CD4+CD8 -  cells  (37,  and  Fig.  5 g).  As previously 
observed, coexpression of  a constitutive CD8.1 transgene leads 
to  an increased  number of anti-HY  TCR+CD4-CD8.2 + 
thymocytes,  but  does  not  permit  the  development  of 
CD4+CD8.2 -  cells  bearing  the  anti-HY  TCR  (16,  and 
Fig.  5  h).  In contrast,  coexpression  of the  hybrid  CD884 
transgene leads to the appearance of a significant population 
of anti-HY TCR+CD4+CD8.2 -  cells  (Fig.  5  t).  On close 
examination,  however,  it  is  apparent  that  this  population 
expresses  low levels  of endogenous  CD8,  suggesting that 
they may not be fully mature. 
If CD4 +  thymocytes expressing  the  anti-HY  TCR  are 
fully mature,  they should  emigrate  from the  thymus  and 
populate the periphery. To examine this question, we ana- 
lyzed peripheral  T  cells  of anti-HY  TCR/CD884  mice. 
Expression of the anti-HY TCR  in peripheral T  cells  of fe- 
male  H-2  b mice  is  generally  low  due  to  extensive  rear- 
rangements of endogenous TCR  c~ genes (37) and periph- 
eral  selection  for  cells  that  do  not  express  the  anti-HY 
Total Thymus 
c~-FI-Y  TCR tg  c~-H-Y  TCR/  c~-H-Y  TCR/ 
CD8.1 tg  CD884  tg 
CD8.2 
a-H-Y TCR 
a-H-Y TCR High 
,~  ]0.3  !7.7g  }0.6/44i~~ 
CD8.2 
Figure  5.  Thymic subsets in female mice coexpressing the anti-HY 
TCR and the CD884 transgenes. Expression of CD4, CD8.2 (endoge- 
nous CD8), and anti-HY TCR (T3.70) in  thymocytes from anti-HY 
TCR (a, d, andg), anti-HY TCR/CD8.1 (b, e, and h), or anti-HY TCR/ 
CD884 (c,f,, and t) transgenic mice. Thymocytes were analyzed by three- 
parameter flow cytometry using fluorescent antibodies as described in 
Materials and Methods. The numbers inside the quadrants represent the 
percentage of cells in each population. Total thymocytes (a-j)  or thy- 
mocytes expressing high levels of anti-HY TCR (g-J) are shown. The 
gate for discriminating anti-HY TCR high thymocytes  is indicated (d-f). 
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Figure 6.  Lymph node T cells in female mice coexpressing the anti- 
HY TCR and the CD884 transgenes. Expression of CD4, CD8.2 (en- 
dogenous CD8), and anti-HY TCR in lymph node T cells from anti-HY 
TCR (a, d, andg), anti-HY TCR/CD8.1 (b, e, and h), or anti-HY TCR/ 
CD884 (c, f  and 0 transgenic mice. The numbers inside the quadrants 
represent the percentage of cells in each population. Four mice of each 
genotype  were analyzed  and representative data are shown. T cells (B-deple- 
ted lymph node cells) were analyzed by three-parameter flow cytometry 
using fluorescent antibodies as described in Materials and Methods. 
TC1K (38). There is, however, a distinct population of CD8 
cells  expressing high levels of the  anti-HY TCP,  (37,  and 
Fig.  6,  a  and  d).  Coexpression  of a  constitutive  CD8.1 
transgene  leads  to  an  increase  in  anti-HY  TCR+CD8.2 + 
lymph  node  T  cells,  but  does  not  increase  the  anti-HY 
TCR+CD4 +  population  (16,  and  Fig.  6,  b,  e,  and  h).  In 
mice  expressing both  the  CD884  and  the  anti-HY  TCR 
transgene,  there  is  a  further  increase  in  the  anti-HY 
TCP,+CD8 + population (Fig. 6, c and f). It is important to 
note that there is also a small  (1%)  but  distinct population 
of CD4  cells  expressing high levels  of the  anti-HY  TCIK 
(Fig.  6  I]. Taken together,  these data indicate  that expres- 
sion  of the  CD884  transgene  permits  the  development  of 
some anti-HY TCR + CD4 lineage cells.  However, unlike 
the F5 TCR, for which coexpression of the CD884 trans- 
gene leads to a predominance of CD4 cells over CD8 cells, 
coexpression  of  the  CD884  protein  with  the  anti-HY 
TCP,  produces  predominately  CD8  lineage  T  cells  and 
only a small number of mature CD4 lineage cells. 
Discussion 
In this paper we show that expression of a hybrid mole- 
cule consisting of the extracellular and transmembrane por- 
tions of CD8 and the cytoplasmic portion of CD4 leads to 
the  development  of large  numbers  of mature  class  I~spe- 
cific, CD4 + T  cells.  In contrast,  expression  of a wild-type 
CD8  transgene  at  comparable  levels  allows  only  a  small 
number  of class  1--specific,  CD4  lineage  cens  to  develop. 
These results indicate that the cytoplasmic tail of CD4 de- 
livers an intracellular signal that favors the development of 
CD4 lineage T  cells.  This observation provides a molecular 
basis  for  differential  signaling  in  response  to  class  I  or  II 
MHC recognition during thymic development which could 
serve to direct the CD4/CD8 lineage decision. 
One feature of our data is most compatible with instruc- 
tive  models for lineage  commitment.  We  find  that in  F5 
TCR/CD884  transgenic mice, the increase in CD4 lineage 
cells is accompanied by a decrease in the mature CD8 pop- 
ulation.  This decrease in the  mature CD8 compartment is 
seen even when the F5 TCR/CD884-bearing thymocytes 
represent a minority of total thymocytes, indicating that the 
effect  is  not  due  to  cellular  competition.  Whereas  an  in- 
structive  model predicts  that mature  CD4  cells  might ap- 
pear at the expense of CD8 cells,  ifCD884 expression "res- 
cues" already committed CD4 lineage cells, it is not obvious 
why the development of CD8 lineage cells should be im- 
paired.  Because  this  feature  of the  data  is  not readily  ex- 
plained  by  a  stochastic  model,  we  favor  the  explanation 
that  the  CD884  hybrid molecule  acts at  an  uncommitted 
stage of T  cell development to instruct cells to choose the 
CD4 lineage. 
The  different  abilities  of the  CD884  hybrid coreceptor 
and wild-type CD8 to generate class I-specific, CD4 lineage 
T  cells focuses attention  on the CD4 cytoplasmic domain. 
What feature of these 31 amino acids favors the development 
of CD4 lineage cells?  The CD4 cytoplasmic domain inter- 
acts with the tyrosine kinase Lck, raising the possibility that 
Lck is ultimately responsible for the effects of the CD4 cy- 
toplasmic domain on T  cell development. If this is the case, 
this effect is likely to be quantitative, because the cytoplasmic 
domain of CD8o~ also interacts with Lck, albeit more weakly 
(27-29).  It is also possible  that there  are qualitative  differ- 
ences between the  CD4 and CD8 intracellular signals and 
that as yet unidentified signaling molecules are associated with 
CD4 or CD8.  Experiments  to identify more precisely the 
region of the CD4 tail that is responsible for these effects are 
in progress. 
The quantitative difference in the ability of CD4 and CD8 
to associate with and activate Lck suggests a possible expla- 
nation for the effect of the CD4 cytoplasmic tail on T  cell 
fate. Signal transduction through the TCR occurs via a series 
of tyrosine phosphorylations and involves the sequential in- 
teraction of at least two tyrosine kinases,  Lck and ZAP-70 
(for a review see reference 39). We suggest that the quantity 
of Lck associated with the TCR complex during MHC rec- 
ognition might impose a bias on lineage commitment, such 
that MHC  engagement that produces weak Lck activation 
would  be  more  likely  to  result  in  CD8  lineage  cells, 
whereas strong Lck activation would be more likely to re- 
sult  in  CD4  lineage  cells.  Because  CD8  binds  Lck  more 
weakly than CD4, class I MHC  recognition would tend to 
produce CD8 lineage cells,  whereas class II MHC recogni- 
tion would be  more likely to produce  CD4  lineage  cells. 
Although differential recruitment  of Lck by CD4 or CD8 
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level of Lck associated with the TCR could be affected by 
other factors as well.  It has been shown that phosphoryla- 
tion of the ~ chain of the TCR by Lck and recruitment of 
ZAP-70 can occur in the absence of CD4 and CD8,  im- 
plying that there  are multiple pathways for activating Lck 
(for a review see reference 39).  Although  other means  of 
recruiting  Lck  to  the  TCR  complex  have  not  yet been 
characterized,  it is possible that additional  factors,  such  as 
the extent of TCP,, cross-linking by MHC, could affect the 
level of Lck in the TCR complex and influence the CD4/ 
CD8 lineage decision independently of coreceptor engage- 
merit. 
Obviously, quantitative considerations alone cannot ex- 
plain  the  strict  correlation  between  TCR  specificity and 
CD4  or  CD8  lineage  commitment  that  is  normally  ob- 
served.  However,  indications  that  positive  selection  may 
require prolonged TCR  engagement (40,  41),  along with 
the observation that constitutive coreceptor expression can 
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Figure 7.  A  quantitative, instructive model for the CD4/CD8 hneage 
decision. This model is based on the assumption that positive selection is 
not a  "single-hit" event, and that MHC engagement influences the lin- 
eage choice of an uncommitted thymocyte. The width of the arrow de- 
notes the proportion of thymocytes that take a particular pathway and the 
the darkness of the arrow indicates the extent of Lck activation. Accord- 
ing to this model, MHC recognition that leads to weak activation of Lck 
biases development to the CD8 lineage, whereas MHC recognition that 
leads to strong Lck activation biases toward the CD4 lineage. Most thy- 
mocytes bearing class II-specific TCRs would receive a strong Lck signal 
(due to Lck activation by CD4) and would begin to downregulate CD8. 
These tliymocytes would continue to receive a strong intraceflular signal 
through the TCR  and CD4,  and would therefore continue to  mature. 
Most cells  bearing class  I-specific TCRs would receive a  weaker signal 
(due to weak Lck activation by CD8) and would downregnlate CD4. A 
continued weak signal through TCP,. and CD8 would permit their final 
maturation. The requirement for continued MHC recognition after the 
downregulation of one of the coreceptors serves as a "confirmation" step 
to insure that cells  that downregulate the wrong coreceptor do not ma- 
ture. Note that if cells that have begun CD8 downregnlation are not yet 
lineage colrlmitted (8), then the confirmation step could also influence the 
lineage choice of uncommitted cells. 
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sometime "rescue" cells of the wrong lineage  (9-15),  sug- 
gest  that  there  is  a  "confirmation  step"  after  the  initial 
MHC  encounter.  Based  on these  observations, as well as 
our data,  we  favor the  model  depicted  in  Fig.  7.  In  this 
model, the initial  encounter with MHC leads to a bias in 
lineage commitment such that most thymocytes expressing 
class II-specific TCRs receive a strong signal and begin to 
downregulate  CD8.  However,  some  thymocytes bearing 
class II-specific TCRs  (perhaps those with weaker avidity 
for peptide/MHC on thymic epithelial cells) turn off CD4 
instead.  Because  CD4  would  be  required  for  continued 
class II-specific TCRs that retain expression of CD4 could 
survive, whereas those that have downregulated CD4 would 
die,  Likewise, most cells  expressing class I-specific TCR.s 
would receive a weaker Lck signal and would downregu- 
late CD4. Cells that continue to receive a weak signal could 
complete maturation to a CD8 lineage.  Thymocytes with 
class I-specific TCRs  that  receive a  stronger TCk  signal 
might downregulate  CD8 instead of CD4, however those 
cells would not complete maturation to a CD4 hneage be- 
cause of the continued requirement for class I recognition 
throughout maturation. 
It is interesting to consider the possibility that the confir- 
mation step might also be instructive, i.e., that it may affect 
the lineage decision of an uncommitted cell.  Although it is 
often assumed that CD4+CD8  l~  thymocytes are commit- 
ted to a CD4 lineage, there is litde evidence supporting this 
assumption.  Indeed,  intrathymic  transfer of CD4+CD8  l~ 
thymocytes indicates that some of these cells can differenti- 
ate into CD8 lineage cells  (8). If CD4+CD8 l~  thymocytes 
are  uncommitted,  then  the  signal  that  they receive  upon 
MHC  recognition  might  be  instructive.  A  strong  signal 
would  lead  them  to become CD4  cells,  whereas  a  weak 
signal would divert them to the CD8 lineage. 
This quantitative model may provide an explanation for 
the different effects of the CD884  transgene on two indi- 
vidual class I-specific TCR.s. If  the F5 TCR is relatively ef- 
fective at generating an intracellular signal (due to the high 
avidity of the F5 TCR. for peptide/MHC or due to a high 
density of the positive-selecting ligand on thymic epithelial 
cells),  then  the  Lck  associated  with  the  CD884  protein 
might  be  sufficient  to  divert  the  majority of cells  to  the 
CD4  lineage.  On  the  other  hand,  thymocytes expressing 
the anti-HY TCP,. might experience a relatively weak in- 
tracellular signal during positive selection.  If that were the 
case,  then increasing the activation of Lck by engaging the 
CD884 protein might not be sufficient to complete matu- 
ration to the CD4 lineage. It is interesting to note that the 
thymus ofanti-HY TCRJCD884 transgenic mice contains 
a very prominent CD4+CD8 l~  population.  This may re- 
flect the fact that thymocytes expressing both the anti-HY 
TCR and CD884 transgenes receive a stronger intracellular 
signal that may be sufficient to downregulate CDS, but not 
to permit complete maturation to the CD4 lineage. 
Earlier studies  (42)  indicated  that CD4 intracellular sig- 
nals are dispensable for the development of some CD4 lin- 
eage cells.  At first glance, these results appear to contradict 
the role for the CD4 cytoplasmic tail indicated here. How- ever, it is possible that the CD4 cytoplasmic tail could pro- 
mote the development of CD4 lineage cells and still not be 
essential  for the  development  of all  CD4  cells.  The  CD4 
cells that develop in the absence of a CD4 cytoplasmic tail 
may bear  high  avidity TCRs  that  would  generate  strong 
intracellular  signals.  Such cells  might  not require  the  Lck 
associated with CD4 in order to develop into CD4 lineage 
T  cells.  The fact that the substitution of physiological levels 
of tail-less  CD4 for endogenous CD4 restores only a frac- 
tion of the normal numbers of mature CD4 cells is consis- 
tent with this explanation. 
An earlier  report  describing a  hybrid CD8/CD4  trans- 
gene (18)  differs from our results in a number of important 
respects.  In the previous report, a population of peripheral 
T  cells expressing both CD4 and endogenous CD8 was ob- 
served.  We  see no  evidence for such a population  in our 
studies. Moreover, in a preliminary study, expression of the 
previously described CD8/CD4 hybrid transgene in class II 
mutant  mice  did  not  produce  an  increase  in  the  mature 
CD4  population  (Jane  Pames,  personal  communication). 
The failure to generate class I-specific CD4 cells using this 
particular  hybrid coreceptor could be due  to the  fact that 
CD813 was not coinjected with the CD8/CD4 hybrid trans- 
gene  or  due  to  the  level  or  timing  of expression  of the 
transgene.  It may also be relevant that our CD8/CD4  hy- 
brid  transgene  uses  the  transmembrane  segment  of CDS, 
whereas  the  one  described  in  the  earlier  study  uses  the 
transmembrane segment of CD4. 
A number of recent studies have emphasized the stochas- 
tic nature of the process of CD4/CD8  lineage commitment 
and the lack of an absolute requirement for CD4 and CD8 
intracellular  domains  in  thymic  development.  In  spite  of 
this, the critical issue of whether intracellular signals gener- 
ated upon MHC  recognition influence the fate of uncom- 
mitted thymocytes remains unresolved. The data in our pa- 
per clearly demonstrate  that the  CD4 intraceUular domain 
does play an important role in the CD4/CD8 lineage deci- 
sion. Moreover, our data are most compatible with the no- 
tion that CD4 intracellular signals act on uncommitted thy- 
mocytes to influence their lineage decision. 
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